• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » BIO adds Gary Andres as senior executive vice president of Public Affairs

BIO adds Gary Andres as senior executive vice president of Public Affairs

February 16, 2017
CenterWatch Staff

The Biotechnology Innovation Organization (BIO) has announced that long-time Majority Staff Director of the House Energy and Commerce Committee Dr. Gary Andres will be joining BIO as senior executive vice president of Public Affairs.

“I am delighted to have Gary join the BIO team. He brings a wealth of experiences and skills to this critical advocacy position. Gary has a deep understanding of Washington, Congress, the White House and our industry. BIO’s executive leadership team and the BIO Board of Directors look forward to Gary helping us improve the public policy environment for continued innovation,” said Jim Greenwood, president & CEO of BIO.

As Staff Director of the Energy & Commerce Committee, Dr. Andres managed a staff of nearly 70 people and oversaw a $7 million budget. His role included oversight of legislative policy development and strategic communications for all areas of the Committee’s jurisdiction—including healthcare, energy and environmental policy, consumer safety and cyber-security.

Prior to joining the Committee, Dr. Andres served Presidents George H.W. Bush and George W. Bush as Deputy Assistant to the President for Legislative Affairs (1989-1992) and as a member of the Cabinet Confirmation team (2001).

Greenwood continued, “Gary is joining BIO at a critical time for our industry. The respect Gary commands—from both sides of the aisle—will be a tremendous asset to our organization and our industry. His experience and management skills will help us elevate our advocacy efforts and accomplish our goals – at both the federal and state level.”

Dr. Andres served several stints with Dutko Worldwide (1993-2001/2001-2010)—serving first as a partner and Vice President and then as Vice Chairman for Research, overseeing the firm’s polling and strategic communications offerings. He also served as Vice President for Washington Research at Prudential Securities and as Director of Government Relations for the former Southwestern Bell Corporation (now AT&T).

From 2002-2010, he wrote regular columns for the Washington Times and The Weekly Standard—and has been an occasional contributor to Roll Call, The Hill, Politico and National Review Online. In 2009, Andres published the book, “Lobbying Reconsidered.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing